Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Cools

Showing results (131-140 of 155) with videos related to

Pageof 16
Sort By:
Leukemia|February 16, 2007
A new NDE1/PDGFRB fusion transcript underlying chronic myelomonocytic leukaemia in Noonan SyndromeR La Starza, R Rosati, G Roti, et al.
Leukemia|January 12, 2007
FIP1L1-PDGFRA in chronic eosinophilic leukemia and BCR-ABL1 in chronic myeloid leukemia affect different leukemic cellsB Crescenzi, A Chase, R La Starza, et al.
Medrxiv : the Preprint Server for Health Sciences|December 25, 2025
Internal and External Validation of Comprehensive High-Frequency Activity Biomarkers for Epilepsy SurgeryKeisuke Hatano, Naoto Kuroda, Hiroshi Uda, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|June 20, 2026
Internal and external validation of comprehensive high-frequency activity biomarkers for epilepsy surgeryKeisuke Hatano, Naoto Kuroda, Hiroshi Uda, et al.
Leukemia|February 20, 2004
Clinical and molecular features of FIP1L1-PDFGRA (+) chronic eosinophilic leukemiasP Vandenberghe, I Wlodarska, L Michaux, et al.
Leukemia|September 21, 2018
Correction: Mutant JAK3 phosphoproteomic profiling predicts synergism between JAK3 inhibitors and MEK/BCL2 inhibitors for the treatment of T-cell acute lymphoblastic leukemiaS Degryse, C E de Bock, S Demeyer, et al.
Leukemia|August 31, 2017
Mutant JAK3 phosphoproteomic profiling predicts synergism between JAK3 inhibitors and MEK/BCL2 inhibitors for the treatment of T-cell acute lymphoblastic leukemiaS Degryse, C E de Bock, S Demeyer, et al.
Medicine and Science in Sports and Exercise|July 15, 2022
Relationship between Anterior Pituitary Volume and IGF-1 Serum Levels in Soldiers with Mild Traumatic Brain Injury HistoryAnna K Castellano, Jacob R Powell, Michael J Cools, et al.
International Journal of Cancer|April 13, 2017
Gram-positive pneumonia augments non-small cell lung cancer metastasis via host toll-like receptor 2 activationStephen D Gowing, Simon C Chow, Jonathan J Cools-Lartigue, et al.
Leukemia|June 26, 2015
Characterization of the genome-wide TLX1 binding profile in T-cell acute lymphoblastic leukemiaK Durinck, W Van Loocke, J Van der Meulen, et al.
Pageof 16

Showing results (131-140 of 155) with videos related to

Sort By:
Pageof 16
Leukemia|February 16, 2007
A new NDE1/PDGFRB fusion transcript underlying chronic myelomonocytic leukaemia in Noonan SyndromeR La Starza, R Rosati, G Roti, et al.
Leukemia|January 12, 2007
FIP1L1-PDGFRA in chronic eosinophilic leukemia and BCR-ABL1 in chronic myeloid leukemia affect different leukemic cellsB Crescenzi, A Chase, R La Starza, et al.
Medrxiv : the Preprint Server for Health Sciences|December 25, 2025
Internal and External Validation of Comprehensive High-Frequency Activity Biomarkers for Epilepsy SurgeryKeisuke Hatano, Naoto Kuroda, Hiroshi Uda, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|June 20, 2026
Internal and external validation of comprehensive high-frequency activity biomarkers for epilepsy surgeryKeisuke Hatano, Naoto Kuroda, Hiroshi Uda, et al.
Leukemia|February 20, 2004
Clinical and molecular features of FIP1L1-PDFGRA (+) chronic eosinophilic leukemiasP Vandenberghe, I Wlodarska, L Michaux, et al.
Leukemia|September 21, 2018
Correction: Mutant JAK3 phosphoproteomic profiling predicts synergism between JAK3 inhibitors and MEK/BCL2 inhibitors for the treatment of T-cell acute lymphoblastic leukemiaS Degryse, C E de Bock, S Demeyer, et al.
Leukemia|August 31, 2017
Mutant JAK3 phosphoproteomic profiling predicts synergism between JAK3 inhibitors and MEK/BCL2 inhibitors for the treatment of T-cell acute lymphoblastic leukemiaS Degryse, C E de Bock, S Demeyer, et al.
Medicine and Science in Sports and Exercise|July 15, 2022
Relationship between Anterior Pituitary Volume and IGF-1 Serum Levels in Soldiers with Mild Traumatic Brain Injury HistoryAnna K Castellano, Jacob R Powell, Michael J Cools, et al.
International Journal of Cancer|April 13, 2017
Gram-positive pneumonia augments non-small cell lung cancer metastasis via host toll-like receptor 2 activationStephen D Gowing, Simon C Chow, Jonathan J Cools-Lartigue, et al.
Leukemia|June 26, 2015
Characterization of the genome-wide TLX1 binding profile in T-cell acute lymphoblastic leukemiaK Durinck, W Van Loocke, J Van der Meulen, et al.
Pageof 16